爱特医疗
ATRC
56.07
-1.71
-2.96%
爱特医疗
US · ATRC
#2543 按市值排名
上市于 1970
56.07
-1.71
-2.96%
实时 - 追踪5344个代码 - 心跳于566秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
涨跌不一/平稳
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 105.53% -0.01pp
- 机构数量
- 307
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund88.01%
Hedge Fund11.56%
Individual/Insider4.01%
Public Company2.70%
Private Company1.01%
Sovereign Wealth Fund0.74%
Insurance Company0.73%
Government Pension Fund0.72%
主要股东 截至 2026-06-30
BlackRock
8.80% · 4.47M 股
Wellington Management Group
6.87% · 3.50M 股
Vanguard Portfolio Management, LLC
6.15% · 3.13M 股
Hood River Capital Management LLC
5.71% · 2.91M 股
AllianceBernstein
5.44% · 2.77M 股
Vanguard Capital Management, LLC
5.01% · 2.55M 股
Macquarie Investment Management Business Trust
3.41% · 1.73M 股
Goldman Sachs Asset Management, L.P.
2.91% · 1.48M 股
State Street Global Advisors
2.73% · 1.39M 股
Marshall Wace LLP
2.62% · 1.33M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 22次买入 · 28次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Michael Carrel | Chief Executive Officer | 1.56% |
| Douglas Seith | Chief Operating Officer | 0.45% |
| Angela Wirick | Chief Financial Officer | 0.40% |
| Salvatore Privitera | Chief Technology Officer | 0.28% |
| Robert White | Independent Director | 0.25% |
| Justin Noznesky | Chief Marketing & Strategy Officer | 0.20% |
| Karl Dahlquist | Chief Legal Officer | 0.17% |
| Vinayak Doraiswamy | Chief Scientific Officer | 0.17% |
| B. Johnson | Independent Chairperson | 0.11% |
| Deborah Yount | Chief Human Resources Officer | 0.09% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-22 | Salvatore Privitera | Chief Technology Officer | Automatic Disposition | -4,519 | $60.00 |
| 2026-09-10 | Regina Groves | Independent Director | Open Market Disposition | -5,313 | $54.22 |
| 2026-09-09 | Regina Groves | Independent Director | Intent to Sell (Form 144) | -5,313 | $53.66 |
| 2026-09-07 | Salvatore Privitera | Chief Technology Officer | Automatic Disposition | -3,657 | $55.00 |
| 2026-09-01 | Salvatore Privitera | Chief Technology Officer | Automatic Disposition | -7,763 | $52.50 |
| 2026-08-23 | Karl Dahlquist | Chief Legal Officer | Open Market Disposition | -9,370 | $48.89 |
| 2026-08-04 | Karen Prange | Independent Director | Open Market Disposition | -3,564 | $38.80 |
| 2026-08-04 | Maggie Yuen | Independent Director | Open Market Disposition | -3,500 | $38.42 |
| 2026-07-29 | Michael Carrel | Chief Executive Officer | Other Disposition | -4,700 | -- |
| 2026-07-28 | Justin Noznesky | Chief Marketing & Strategy Officer | Open Market Disposition | -6,182 | $38.80 |
| 2026-07-27 | Sven Wehrwein | Independent Director | Derivative Exercise and Sale | -25,000 | $19.95–37.84 |
| 2026-07-27 | Vinayak Doraiswamy | Chief Scientific Officer | Open Market Disposition | -6,000 | $38.88 |
| 2026-06-29 | Michael Carrel | Chief Executive Officer | Other Acquisition | +636 | $23.78 |
| 2026-06-29 | Salvatore Privitera | Chief Technology Officer | Other Acquisition | +636 | $23.78 |
| 2026-06-29 | Douglas Seith | Chief Operating Officer | Other Acquisition | +527 | $23.78 |
| 2026-06-29 | Karl Dahlquist | Chief Legal Officer | Other Acquisition | +636 | $23.78 |
| 2026-06-29 | Vinayak Doraiswamy | Chief Scientific Officer | Other Acquisition | +636 | $23.78 |
| 2026-05-19 | Karen Prange | Independent Director | Open Market Disposition | -3,000 | $28.65 |
| 2026-05-17 | Sven Wehrwein | Independent Director | Other Acquisition | +6,144 | -- |
| 2026-05-17 | B. Johnson | Independent Chairperson | Other Acquisition | +6,144 | -- |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
爱特医疗 讨论区 0 条评论